glp-1 in type 2 diabetes drugs are all approved for glucose control (T2D). Some of them also have additional indications reflecting their demonstrated benefits for cardiovascular disease, kidney health, and obesity. None New GLP-1 Guidelines for Type

Unlike many other peptide therapies, GHK-Cu typically isnt administered as an injectable

Additional factors such as increased release of adiponectin from adipose tissue, amelioration of insulin resistance in liver and peripheral tissues, and improved circulatory lipid profile all contribute to the reduced risk of ASCVD (267)

But for now it is important that patients prescribed GLP-1 drugs have conversations with their healthcare providers about strategies to preserve muscle mass

BMI, Diet, and Lifestyle Requirements Insurance May Expect Most insurers require documentation showing that GLP-1 therapy is medically necessary

I grew up quite active, dancing and playing volleyball